AF
BIO icon

Align Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Align Financial’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.69K Hold
33
– – ﹤0.01% 262
2026
Q1 		$9.2K Sell
33
-9,966
-100% -$2.87M 0.01% 271
2025
Q4 		$10K Buy
+9,999
New +$3.12M 0.01% 277

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Align Financial's BIO Position: Q2 2026 in Review

Align Financial held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 33 shares worth $9.69K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Align Financial first reported a position in BIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $10K in Q4 2025. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Align Financial held 33 shares of Bio-Rad Laboratories Class A worth $9.69K as of Q2 2026.
  • Align Financial left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Align Financial's portfolio in Q2 2026, its #262 holding.
  • Align Financial first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 3 quarters since.
  • Align Financial's Bio-Rad Laboratories Class A position peaked at $10K in Q4 2025.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Align Financial's 13F filing for Q2 2026, filed 27 Jul 2026.